NCLAT: Can’t Dismiss Restoration App. if Filed in 30 Days from Date of Dismissal of Original App.  ||  Delhi HC: Communication between Parties through Whatsapp Constitute Valid Agreement  ||  Delhi HC Seeks Response from Govt. Over Penalties on Petrol Pumps Supplying Fuel to Old Vehicles  ||  Centre Notifies "Unified Waqf Management, Empowerment, Efficiency and Development Rules, 2025"  ||  Del. HC: Can’t Reject TM Owner’s Claim Merely because Defendant Could have Sought Removal of Mark  ||  Bombay HC: Cannot Treat Sole Director of OPC, Parallelly with Separate Legal Entity  ||  Delhi HC: Can Apply 'Family of Marks' Concept to Injunct Specific Marks  ||  HP HC: Can’t Set Aside Ex-Parte Decree for Mere Irregularity  ||  Cal. HC: Order by HC Bench Not Conferred With Determination by Roster is Void  ||  Calcutta HC: Purchase Order Including Arbitration Agreement to Prevail Over Tax Invoice Lacking it    

Search Results for Tag : diabetes

Judgments

Delhi High Court rules in favour of Merck for its diabetes drug(07.10.2015)

The Delhi High Court restrained Glenmark from selling any drug containing Sitagliptin or its derivate. Sitagliptin is the active ingredient used in ‘J.....

Tags : Glenmark, merck, patent, diabetes



News

Delhi HC Sets Aside Centre's Ban on FDCs for Type-2 Diabetes(18.02.2019)

Delhi High Court has set aside Centre's notifications banning manufacture and sale of fixed drug combinations (FDCs) used for treatment of Type-2 diab.....

Tags : Delhi High Court, FDCs for Type-2 Diabetes



Japan's Mitsubishi Pharma Corporation Loses Patent Bid over Diabetes Drug “Teneligliptin”(14.12.2015)

Kolkata Patent Office on an opposition filed by domestic drug firm Lupin, refused the patent application filed by Japan's Mitsubishi Pharma Corporatio.....

Tags : Kolkata Patent Office, Patent , Diabetes Drug Teneligliptin



Notifications & Circulars

Dr. Jitendra Singh releases 'Indian Guidelines for Diabetes Management'(09.05.2018)

The Union Minister of State (Independent Charge) of the Ministry of Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances.....

Tags : Guidelines, Diabetes Management, Release



Disclaimer | Copyright 2025 - All Rights Reserved